MedPath

TOBTOX

TOBTOX

Discontinued
DIN Number

02233688

Drug Class

Human

Market Date

May 26, 1998

Company
HC

bio active canada ltd.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02233688
AIG Number1532262001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Homeopathic
Product Specifications
Dosage FormLiquid
Route of AdministrationOral
AHFS Classification92:02.00*
Health Canada Classification

ACTIVE INGREDIENTS (15)

BENZENEActive
Strength: 12 X
Monograph: BENZENE
CACTUS GRANDIFLORUSActive
Strength: 3 X
Monograph: CACTUS GRANDIFLORUS
COFFEA TOSTAActive
Strength: 12 X
Monograph: COFFEA TOSTA
DAPHNE INDICAActive
Strength: 3 X
Monograph: DAPHNE INDICA
DELPHINIUM STAPHISAGRIAActive
Strength: 12 X
Monograph: DELPHINIUM STAPHISAGRIA
EUCALYPTUSActive
Strength: 3 X
Monograph: EUCALYPTUS
LOBELIA INFLATAActive
Strength: 3 X
Monograph: LOBELIA INFLATA
LYCOPODIUM CLAVATUMActive
Strength: 12 X
Monograph: LYCOPODIUM CLAVATUM
MENTHOLActive
Strength: 3 X
Monograph: MENTHOL
NAPHTHALENEActive
Strength: 12 X
Monograph: NAPHTHALENE
NITRIC ACIDActive
Strength: 12 X
Monograph: NITRIC ACID
OATSActive
Strength: 1 X
Monograph: OATS
PHOSPHORUSActive
Strength: 12 X
Monograph: PHOSPHORUS
POTASSIUM PHOSPHATE DIBASICActive
Strength: 2 X
Monograph: POTASSIUM PHOSPHATE DIBASIC
TOBACCOActive
Strength: 12 X
Monograph: TOBACCO

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.